CID 11319217

Fostemsavir

Structural Information

Molecular Formula
C25H26N7O8P
SMILES
CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC
InChI
InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)
InChIKey
SWMDAPWAQQTBOG-UHFFFAOYSA-N
Compound name
[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
6
Annotation Hits

77
References

1865
Patents

583.158 Da
Monoisotopic Mass

-0.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 584.16528 222.8
[M+Na]+ 606.14722 231.3
[M+NH4]+ 601.19182 221.3
[M+K]+ 622.12116 236.0
[M-H]- 582.15072 221.6
[M+Na-2H]- 604.13267 225.6
[M]+ 583.15745 222.8
[M]- 583.15855 222.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe